Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Memorial Sloan-Kettering Cancer Center |
---|---|
Information provided by: | Memorial Sloan-Kettering Cancer Center |
ClinicalTrials.gov Identifier: | NCT00610285 |
Stereotactic radiosurgery (SRS) is a way to accurately treat brain tumors. SRS involves the use of a special head frame to keep the head from moving during treatment. The head frame makes very accurate treatment possible. The frame must be attached to the skull with special pins. It feels very tight and can hurt. A special immobilization device can be used to keep the head from moving.
This device does not need any pins and does not hurt. We would like to see if the new way of holding the head still can be used for SRS. This is the purpose of the study. New X-Ray machines can be used to find if the head has moved in the mask. We hope that we can use these new tools to treat brain tumors just as accurately without using a head frame. It will make treatment more comfortable for the patient. This is why we are asking patients to join the study.
Condition | Intervention |
---|---|
Metastatic Brain Cancer |
Radiation: Fabrication of thermoplastic face (The Orfit thermoplastic face mask system is routinely used for the treatment of brain and head) |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label, Single Group Assignment, Efficacy Study |
Official Title: | A Feasibility Study of Image Guided Noninvasive Single Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases |
Estimated Enrollment: | 10 |
Study Start Date: | October 2005 |
Estimated Study Completion Date: | October 2010 |
Estimated Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Histologically confirmed malignancy with the presence of intraparenchymal brain metastases.
|
Radiation: Fabrication of thermoplastic face (The Orfit thermoplastic face mask system is routinely used for the treatment of brain and head)
Before or after the scheduled SRS treatment, patients will undergo an ACQ simulation and fabrication of the Aktina head and neck stereotactic localizer. The attending radiation oncologist will identify on CT scan the intended treatment isocenter. Intravenous contrast will be used for imaging. After CT scan, patients will be immediately transferred to the treatment linear accelerator for a mock treatment setup. Patients will be placed in the intended treatment position using conventional setup lasers.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Yoshiya Yamada, MD | yamadaj@mskcc.org | |
Contact: Jenghwa Chang, PhD | changj@mskcc.org |
United States, New York | |
Memorial Sloan Kettering Cancer Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Yoshiya Yamada, MD yamadaj@mskcc.org | |
Contact: Jenghwa Chang, PhD changj@mskcc.org | |
Principal Investigator: Yoshiya Yamada, MD |
Principal Investigator: | Yoshiya Yamada, MD | Memorial Sloan-Kettering Cancer Center |
Responsible Party: | Memorial Sloan-Kettering Cancer Center ( Yoshiya Yamada, MD ) |
Study ID Numbers: | 05-110 |
Study First Received: | January 14, 2008 |
Last Updated: | November 3, 2008 |
ClinicalTrials.gov Identifier: | NCT00610285 |
Health Authority: | United States: Institutional Review Board |
Brain Neoplasms Neoplasm Metastasis Central Nervous System Diseases |
Central Nervous System Neoplasms Brain Diseases Nervous System Neoplasms |
Neoplastic Processes Neoplasms Pathologic Processes Neoplasms by Site Nervous System Diseases |